Literature DB >> 32856615

Role of PDK4 in insulin signaling pathway in periadrenal adipose tissue of pheochromocytoma patients.

Chunyan Wu1, Huijian Zhang2, Xiaochun Lin1, Yanmei Zeng1, Yudan Zhang1, Xiaoqin Ma1, Yaoming Xue1, Meiping Guan1.   

Abstract

Studies have shown that pheochromocytoma (PHEO) is associated with glucose intolerance and decreased insulin sensitivity. In adipocytes, pyruvate dehydrogenase kinase 4 (PDK4) is involved in glucose uptake. However, very little is known about the role of PDK4 in the insulin signaling pathway in the adipose tissue of PHEO patients. We analyzed the expression of adipokines, oxidative stress-related genes, PDK4, phosphorylated AMPK (pAMPK) and phosphorylated IRS1 (pIRS1) in the periadrenal adipose tissue (peri-A) of patients with PHEO and non-functioning adrenal adenoma (NFA). We also investigated the effects of epinephrine on PDK4, pAMPK and pIRS1 in human stromal vascular fraction (SVF) cells, mouse 3T3-L1 preadipocytes and brown preadipocytes. PHEO patients had higher mRNA levels of PGC1α, C/EBPα, C/EBPβ, COXII and AP2 and lower mRNA levels of PPARγ in their peri-A than NFA patients. Decreased pAMPK and increased PDK4 and pIRS1 were observed in the peri-A of PHEO patients. PHEO patients also had significantly higher NOX4 protein expression and lower Nrf2 and HO-1 protein expression in their peri-A than NFA patients. In vitro, epinephrine treatment upregulated PDK4 expression, inhibited AMPK phosphorylation and enhanced IRS1 phosphorylation. The knockdown of PDK4 by siRNA upregulated pAMPK and downregulated pIRS1. In conclusion, PDK4 may play an essential role in hypercatecholamine-induced insulin resistance in the periadrenal adipose tissues of PHEO patients.

Entities:  

Keywords:  AMPK; IRS1; PDK4; adipose tissue; epinephrine; pheochromocytoma

Year:  2020        PMID: 32856615     DOI: 10.1530/ERC-20-0293

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  2 in total

1.  BATF2 and PDK4 as diagnostic molecular markers of sarcoidosis and their relationship with immune infiltration.

Authors:  Jie He; Xiaoyan Li; Jing Zhou; Rong Hu
Journal:  Ann Transl Med       Date:  2022-01

2.  Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases.

Authors:  Esther P Jane; Daniel R Premkumar; Dhivyaa Rajasundaram; Swetha Thambireddy; Matthew C Reslink; Sameer Agnihotri; Ian F Pollack
Journal:  Mol Oncol       Date:  2021-06-23       Impact factor: 6.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.